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The extent of mast cell direct involvement in fibrosis 
is not defined as yet. In the present study we assessed 
whether long-term co-culture (up to 7 d) offunction-
ally active rat peritoneal mast cells with 3T3 mouse 
fibroblasts and nlast cell activation can affect fibro-
blast proliferation and collagen production. Co-cul-
ture of subconfluent 3T3 fibroblasts with resting mast 
cells or with mast cells stimulated by aIgE (1:35) or 
repeatedly activated by low concentrations of com-
pound 48/80 (0.25-0.75 /A-g/ml) did not alter fibroblast 
proliferation. However, fibroblast proliferation was 
increased significantly (100-130%) when mast cells 
were repeatedly activated with higher concentrations 
of compound 48/80 (1-3 /A-g/ml). Repeated mast cell 
T he cardinal role of mast cells in type I hypersensitiv ity reactions is well established. However, mast cells have been implicated in the photogenesis of a nU111-b. er of chJ'ollic inflammatory conditions that result in fibrosis such as idiopathic lung fibrosis , keloids and 
hypertrophy scars, scleroderma, and chronic graft-versus-host dls-
ease [1] . In these conditions mast cells undergo changes in numbers 
and morphology that correlate with th e course of fibrosis develop-
m ent [2 ,3]. These observations provide only circumst'1I1tial evi-
dence that mast cells have a role ill causulg fibroblasts to express a 
fibrotic phenotype . However, ill lIifro studies aimed to analyze the 
direct effects of mast cells on fibroblast biochemical properties are 
still few and scattered [4-7] . 
We have developed in the past a mast cell / 3T3 fibroblast 
co-culture in which viability and functional activity of rat peritoneal 
mast cells are maintained for more than a month [8]. Exploiting this 
co-culture we have demonstrated that when a linear "wound" is 
performed in the fibroblast monol ayer and half the monolayer is 
scraped cell free , m ast cell presence signific'U1.tiy enlul11ces fibro-
blast migration and prolife ration into the wound space [4]. 
In the present work, to further anal yze mast cell-fibroblast 
interactions in fibrosis w e have investigated the effects of mast cell 
presence and activation on 3T3 fibroblast proliferation and collagen 
synthesis by utilizing the mast cell / 3T3 co-culture system. In these 
co-cu ltures mast cells were challenged 1) with anti-IgE antibodies 
in acute-single fasluon, as it happens in hypersensitivity reactions , 
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activation by compound 48/80 (0.25 /A-g/ml) caused a 
twofold increase in collagen production and this was 
reduced by 63% by the mast cell stabilizer nedocromil 
sodium (10-5 M). At the same time, co-culture of3T3 
fibroblasts with unstimulated or immunologically ac-
tivated mast cells did not modulate their collagen 
production. In conclusion, we have demonstrated 
that mast cell activation, under certain conditions, 
can enhance significantly 3T3 fibroblast proliferation 
and collagen production, thus indicating a direct 
mast cell involvement in the fibr~tic processes. Key 
1II00,ds: mast cellslJi·brolllast prolifel'atiotl/collagen synthesis. 
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and 2) with compound 48/80 in repeated-chronic fasluon. T lus was 
done both to produce an activation patte rn different from the one 
takUlg pl ace in hypersensitivity reactions and to minuc what might 
take place in fibroti c diseases. 
MATER.lALS AND METHODS 
Materials Dulbecco's modified Eagle's m edium (DMEM) , L-glutamine. 
streptomycin, penicillin , and fetal bovine serum were obtained fro m 
Biological Industries (Beth Haemek, Israel). Compo und 48/80 was pur-
chased from Sigma (St. Louis, MO). N edocromil sodium was a kind gift of 
Fisons (UK). [' H] labeled proline was from New England Nuclear (Boston, 
MA). Goat anti-rat 19B antibodies (a lgE) were from B ethyl Laboratories 
Inc . (Montgome ry, TX). Steri le tissue culture plastic ware was purchased 
fro m Falcon (Oxford, CAl . C ontact inhibited 3T3 Swiss albino m o use 
fibroblast cell line was obtained fro m T he Amel;can Type C ulture Collec-
tion (Rockville, MD) . 
Mast-Cell Purification Mast cells were obtained from Sabra m ale rats 
(an outbred strain from the H ebrew University) and purified as previously 
described [8]. Purified mast ce ll s (> 95% as assessed b y m etachromasia after 
staining with toluidinc blue). w ere seed ed on 3T3 Swiss Albino mice 
fibroblasts. Mast cells adhere to fibroblast m o no layer in 10 min and re main 
viable and functionally active for m o re than a month [8] . 
3T3 F ibroblast Proliferation 3T3 Swiss albino mi e fibroblasts (3T3) 
were seed ed in 96-well tissue culture plates (3 X 10' cells/well) and 
cu ltured in DMEM supplem ented by 10% heat-inactivated fetal bovine 
serum, 100 u / ml penicillin , 100 ,...g/ ml streptomycin , 2 mM L-glutamine 
(DMEM + ). Mter overnigh t cul ture at 37°C in 5% CO2 , to allow fibrobla st 
adherence, rat peritonealm3St cells (3. 5 X 10' mast cell s/ well) were seeded 
onto the fibrob lasts. In one experiment different m ast cell numbe rs (80-
5000 mast cell s/ well) were seeded. O ne day after sceding the m ast cells, 
culture 1'1lcdiull'l \ IV:lS aspirated and no n-adhere nt cell s \verc r Cllloved by 
washing the mono layer with 2 ml of fresh m edium. T hereafter, m ast cell 
activation was performcd by adding compound 48/80 (0. 25- 3 ,...g/ ml) . 
Every 2-3 d m ediulll was replaced by a fresh one containing th e sam e 
amollnt of the m ast ce ll activator. In ano ther series of experiments, mast 
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Figure 1. Co-culture of resting mast cells (MC) with 3T3 fibroblasts 
does not affect fibroblast proliferation. 3.5 X 10' MC were seeded on 
day 0 on 3T3 fibroblasts . Fibroblast numbers were determined at the 
indicated days. Data arc mean ±: SEM of seven experiments performed in 
triplicates . 
cells were single-time activated by an optimal concentration of algE 
antibodies (1 :35, 1 d after seeding). Periodically (every 2-3 d) fibroblasts 
were obta ined by trypsinization and counted by the use of a hemocytom-
eter. Fibroblast viabiliry was determined by Trypan Blue exclusion test. 
Collagen Production by 3T3 Fibroblasts Collagen production by 
conAuent fibroblast monolayers was assessed by [' H)-proline incorporation 
into collagenous proteins [9]. 3T3 fibroblasts were seeded in 24-wcLl 
tissue-cu]ture plates and grown in DMEM + medium tiJl conAuence. Mast 
cells (1..8 X 10") were seeded on half of the plates and 24 h after seeding the 
plates were wasbed as described above and the cultures were activated. In 
the case of non-immunologic activation, 3T3 and MC/3T3 co-cultures 
were pre-incubated for 4 d with DMEM + (control) or DMEM + containing 
compound 48/80 (0.25 J.Lg/ml) either alone or in combination with 
nedocromil sodium (10- 5 M). The medium was then removed and replaced 
by 0.5 ml of DMEM containing 5% feta l bovine serum, 50 J.Lg/ml 
13-;II11inopropionitrile, 50 J.Lg/ml ascorbic acid , ['H)-proline (10 J.LCi/well), 
and compound 48/80 (alone or together with nedocromil sodium). In the 
case of immunologic activation, mast cells were activated once, 1 dafter 
seeding, by addition of a lgE (1:35) along with the [' H)-proline-containing 
mixture. Cultures were incubated for additional 24 h and ['H)-proline 
incorporation into extracellular collagen was then determined in the 
sllpematant [9). To determine the ce ll number in each well, fibroblast were 
detached by trypsinization on the last day of the experiment and counted. 
Histatnine Release Determination To assess the degree of mast ce ll 
activation in the activation experiments, histamine release was evaluated as 
follows. Mast cell/3T3 were activated by compound 48/80 (0.25-3 J.Lg/ml) 
or a lgE (1 :35). After 20 min incubation at 37°C, supematants were 
collected and mast ccLl /3T3 were scraped with a Teflon poLiceman and 
di srupted by continuous sonication for 1 min (50% duty cycle, H eat sys tem 
Ultrasonics W380) . Supernatants and cell sonicates were stored for hista-
mine assay at - 20°C. Histamine was determined in supernatants and cell 
sonicates by a radioenzymatic assay [10) . The percentage of histamine 
released from mast cells was calculated by dividing the amount of histamine 
in supernatants by the sum of that in supernatants and in cells . 
Statistical Analysis Data arc expressed as mean ±: SEM. Statistical 
analysis was perfonned by the Student I test. p va lues of 0.05 or less were 
considered significant. 
RESULTS 
Mast Cell Activation Enhances 3T3 Fibroblast Proliferation 
First, the elfect of resting, un activated mast cells on fibrob last 
proliferation was assessed. As shown in Fig 1, the presence of 
unactivated mast ce lls (3.5 X 103 mast cells/we ll, 7 d of co-culture) 
on proliferating fibroblasts did not alter the rate of their growth, 
because the fibroblast numbers in c ultures and in co-cultures did 
not differ throughout th e duration of the experiment. In one 
experiment different mast cell numbers (80-5000 mast cells/well) 
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Figure 2. Mast cell (MC) activation by compound 48/80 enhances 
3T3 fibroblast proliferation. 3.5 X 10' MC were seeded on 3T3 
fibroblasts. MC/3T3 were activated by compound 48/80 (0.25-3 J.Lg/ml) 1 
d after Me seeding. Fibroblast numbers were evaluated on day 5 after MC 
actj vation and expressed as percent of the cell number in the control group 
(3T3 or MC/3T3 that were incubated with medium alone). Data are mean 
±: SEM of three to nine experiments performed .in triplicates. 
w ere added to the fibroblast monolayer and were found to have no 
effect on fibroblast growth as well (data not shown). 
N ext the influence of a single immunologic mast cell activation 
on 3 T3 fibrob last proliferation was examined. Mast cell activation 
by an optima l concentration of edgE, which induced 25.6 ::!:: 4.4% 
histamine re lease (mean ::!:: SEM, n = 5), did not afFect fibroblast 
proliferation: similar fibroblast numbers were found in resting and 
activated mast cell/3T3 c ultures both on day 2 and 5 after mast cell 
activation [(20.9::!:: 4.1) X 10" cells/well versus (19.3 ::!:: 1.5) X 104 ; 
(48.3 ::!:: 5.1) X 10'1 versus (48.5 ::!:: 2 .2) X 104 ; respectively, mean 
::!:: SEM, n = 3]. Recently we reported that mast cell/3T3 
Inununologic activation results in complete mast cell unresponsive-
ness to a second immuno logic stimulus up to 7 d as evaluated by 
histamine release [11]. On the other hand, mast cells in co-culture 
with 3T3 fibroblasts can fully respond to each rechallenge with 
cOJ'Tlpound 48/80 by releasing percentages of histamine comparable 
to that of control cultures challenged for the first time [12]. We 
therefore evaluated whether mast cell repeated activation carried 
ont by compound 48/80 could alter fibrob last proliferation. To find 
the optimal conditions, different concentrations of tlus mast cell 
aqjvator were added to the cultures 1 d after mast cell seeding and 
at each medium changing (every 2-3 d) and fibrob last numbers 
Were evalu ated. As shown in Fig 2, mast cells that were activated 
by high concentrations of compound 48/80 (1-3 f.Lg/ml) and 
Cotlsequently released lugh percentages of histamine into the 
cnlture medium (50-80%) en hanced significantly 3T3 fibroblast 
proliferation (100-130%, p < 0.01). Lower concentrations of 
cOJ'Tlpound 48/80, wluch released 15-25'Vo histamine, did not alter 
Siglljficantly fibroblast proliferation. It is important to note that 
Cotl"lpound 48/80 did not influence the proliferation of 3T3 fibro-
bl;:J.sts alone, .i.e., in the absence of mast cells (Fig 2). As depicted in 
Fig 3, tlus mast cell enhancing effect was evident and statistically 
sigluflcant only on days 4 and 5 after the first mast cell activation 
(p < 0.05 and p < 0.01, respectively). 
M~st Cell Activation Enhances Collagen Production by 3T3 
Fibroblasts Confluent cultures of 3T3 fibroblasts were cocu l-
tured for 5 d with resting mast cells and their collagen production 
W;:J.S assessed by [H3 ]-proline incorporation into collagenase sensi-
ti\re proteins. The presence of resting mast cells on the monolayer 
slightly but not significantly increased collagen production (1531 ::!:: 
170 cpm/well in the absence of the mast cells and 1820 ::!:: 240 
cptn/well in their presence; .mean ::!:: SEM, n = 9, p > 0.05). 
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Figure 3. Enhancing effect of mast cell (MC) activation by coO'l-
pound 48/80 on the dynamics of fibroblast growth. 3.5 X 10' Me 
were seeded on 3T3 fibroblasts. MC/3T3 were activated by compoul1d 
48/80 (3 J.Lg/ml) 1 dafter MC seeding. Fibroblast numbers were deter-
mined on the indicated days. Data arc mean :t SEM of five experim ents 
performed in triplicates. 
Mast celI /3T3 immunologic activation carried o ut by edgE failed to 
m o dulate collagen synthesis (1950 ::':: 247 cpm /well fo r mast 
cell/3T3 co- cultures and 1716 ::':: 210 cpm /well for mast ce1l/3,!,3 
activated by edgE; m ean::':: SEM, n = 3, p > 0.05). On the other 
hand, mast cells repeated activation by compound 48/80, which 
induced 22 .3 ::':: 4.6% histamine release (mean ::':: SEM, n = 5), led 
to a twofold increase in collagen production (1638 ::':: 72 versos 
3527 ::':: 507 cpm/welI , p < 0.01, Fig 4). Addition of optimal 
con centration [13] of nedocromil sodium (10 - 5 M) together with 
compound 48/80 brought about a decrease of 63% in this enhance-
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Figure 4. Mast cell (MC) activation by compound 48/80 increases 
3T3 fibroblast collagen production and this effect is inhibited Vy 
nedocronlil sodiunl. MC/3T3 cocultures were incubated with com-
pound 48/80 (0.25 J.Lg/ml) alone or ill combination with nedoc[ol1lij 
sodium and collagen synthesis was evaluated as descl;bed in Material., a/'Id 
Meth"ds . In these quiescent-conAuent fibroblast cultures, in which collagen 
synthesis was measured, activation of MC did not inAuellcefibroblilst 
proliferation. Tn f.'Ct, fibroblast numbers were similar in co-cultures stitnu-
latec\ by compound 48/80 [(32.3 :t 4.7) X 10· cells/well] and in those jvst 
incubated with medium [(29.7 :t 2.7) X 10" cells/well]. Data arc mean :t 
SEM of five experiments performed ill triplicates. 
ment (p < 0.05, Fig 4). Under these experimental conditions, 
nedocromil sodium was found to reduce histamine release by 43 ::':: 
12% (mean::':: SEM, n = 5, P < 0.05). Compound 48/80 by itself 
or together with nedocromil sodium did not affect collagen synthe-
sis by 3T3 cultures. Nedocromil sodium also d id not influence the 
basal collagen production of either 3T3 or mast cell/3T3 cultures 
(Fig 4) . 
DISCUSSION 
Mast cells have been postulated to have an important role in fibrosis 
in w hich the two major hallmarks are enhanced collagen synthesis 
by fi broblasts and/or their increased proliferation. There is general 
agreement that increased numbers of mast cells are associated with 
several fi brotic conditions in w hich there is enhanced fibroblast 
proliferation andlor enhanced synthesis of collagen and other 
extracellular matrix products. The suggestion that mast cells p ar-
ticipate in fibrotic diseases stems primarily fi'om morphologic data 
demonstrating, together with dynamic changes in their numbers, a 
change in their ultrastructure indicative of activation [1,2,1 4 - 16]. 
Only few ;/1. lI;t/'O studies would al so indicate the existence of a direct 
and wuque role of mast cells in fibros is [4-7]. 
In the present work our aim was to detennine whether alive and 
functionally active connective tissue- type mast cells , and not just 
mast cell- derived mediators, can directly affect fibroblast proper-
ties. In consequence we h ave utilized an ;11 ,,;tl'O defined system that 
we have developed in the past [8], in which rat p eriton eal mast cells 
(of the connective tissue phenotype) are co-cultured with mouse 
3T3 fibroblasts for up to 7 d. In this study we have also investigated 
the effects of different activation modalities of mast cells on 
fibroblast proliferation and collagen synthesis. Co-cultured mast 
cells were activated either by an 19E-dependent activator (edgE 
antibodies) or by an IgE-independent one (compound 48/80). In 
fact, we aimed to compare the efFects of 1) a mast cell immunologic 
activation that takes place in type I hypersensitivity reactions, which 
ca uses an acute anaphylactic type of histamine release and usually 
does not result in fibrosis, and 2) a m ast cell chronic-repeated 
activation that might be the on e taking place in fibrotic conditions 
in which mast cell stimulation is doubtfully carried out by IgE-
mediated mechanisms. There is in fact some evidence that mast 
cells nught be chronically activated d uring fibrosis deve lopment 
and that this activation differs from the anaphylactic qne [3,17-20]. 
For example, mast cells in th e skin of chronic graft-versus-host 
disease mice show a slow ly developing (over period of weeks) 
granule depletion and cellular activation without evidence of 
granule exocytosis to cell membrane as typically takes place during 
an acute immunologic activation [3,21]. Dvorak and Kissell re-
ported that also in wound healing the morphology of human skin 
mast cells suggested that they underwent a piecemeal type of 
activation rath er than an anaphylactic, IgE-dependent one [1 9]. 
T lus activation pattem has been seen in other fibrotic conditions 
su ch as idiopathic interstitial fibrosis of the lung [20] . In fibrosis, 
mast cell chronic activation is probably caused by the constant 
presence of endogenous stimuli in contrast to mast cell activation in 
allergic diseases, w luch is caused by exogenous antigens through 
IgE-mediated mechanisms . 
Recently we h ave reported that compound 48/80 can activate rat 
mast cells ' to release repeatedly the sanle percentage of lustamine 
over a course of 3-4 activation cycles [12]. Therefore, in tile 
present work, to imitate a chronic-repetitive type of mast cell 
activation , we have exposed mast cells to compound 48/80 for 5-7 
d. It is worth mentioning that mast cell activation carried out by 
compound 48/80 also difl'er from IgE-dependent stimulation in tllat 
compound 48/80 induces histamine secretion in a receptor-inde-
pendent manner, does not require extracellular calcium, and in-
duces different intracellular biochenucal events [22,23]. 
In the present study, we first assessed whether mast cells can 
affect fibroblast proliferation. The most suitable experimental sys-
tem is the one in wluch subconfluent and h ence still expon entially 
growing fibroblast cultures are used. Mast cells were seeded on 
these subconfiuent cultures and fibroblast numbers were assessed at 
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val;o us timc points. R es ting , unactivated mast cells w ere found not 
to affect fibrobl ast proliferation . It was hypothesized that even 
unactivated mast cells might affect fibroblast properties because 
m as t ce]Js have been shown to be able to transfer their granules to 
fib roblasts through a process term ed "transgranulatio n" [24]. 
Tran sgranulation takes place without any sign of mast cell acti va-
tion by deve lopin g specialized ceLl-to-cell contracts between mast 
cells and fibro blasts. N everthelcss in our study cven mast cell 
immuno logic activation and ma st-cell stimulation with lo w con-
ccntrations o f compound 48/80 did not affect fibrobla st prolifera-
tion . However, fibroblast proliferation w as in creased significantl y 
(1 00 -130°1.1 ) when ma st cells w ere repea tedly ac tivated with higher 
concentratio ns of compo und 48/80. D ayton et at demonstrated that 
co-culture of mouse bo ne-marrow-derived mast cells (mucosal-
typc mast cc Ll s) wi th conflucnt 3T3 fibrobl asts Icd to a drastic 
in crease in fib roblast proliferatio n [7] . In th cir mo dcl the fibroblas t 
mo nolayer wa s damaged and fen es trated duc to the effects o f the 
cxponentially growing mast cells caused by thc essential prcsencc of 
in tcrle ukin-3 in the cul ture m edium. Also the presence of activated 
rat perito nea l mast cells o n " w o unded" 3T3 fibro blast monolayers 
sign ifi cantly enhan ced the pro lifera tion and migratio n of fibrobla sts 
into the " wo unded" area [4]. It has been repo rted that the addition 
o f soni cated dog mas tocytoma cells to cultures o f human skin 
fib roblasts caused a threefold increase in cell proli feration [5]. In 
ano the r study mastocytoma cell lin es wcre found to secrete prolif-
erative activi ty fo r hum an , hamster, and rabbit fib roblasts [6]. W e 
have furthcrmore recently noted that incubation of sonicated rat 
perito neal M C with dcrmal fibrobla sts obtained fro m chronic 
graft- versus-host disease patients and from normal individuals 
enhanced th eir prolifera tion by 21-97%. Similarly, the ma st ce ll 
sonicate induced a 20'Yo increase in the proliferation o f normal rat 
fibro blas ts (Garbuzenko E, Nagler A, Rub inchik E , Le vi-Schaffer F, 
unpublished observations). T hese observations show that the e ffect 
of m as t cells on fib robl as t prolife ration is no t restri ctcd to th e 3T3 
murine cell line but occurs also w ith primary nomlal (human and 
rat) and diseased (hum an) fibro blasts. 
Collagen synthesis was determincd in confluent 3T3 fibroblas ts 
co-cul tured with mast cells. Co-cul ture with resting mast cells or 
immunologically activated · mast cells did not signifi cantly alter 
co Llagen production . H o wever, repeated mast cell ac tivation with 
low concentra tions o f compound 48/80 signifi cantly increased 
coll agen produ ction . In contrast it has been reported that mast cell 
pro ducts can stimulate the produ ction o f active collagenase and 
hence participate in collageno lysis as indi cated by experim ents on 
gin giva l [25] and syno vial [26] fibrobla sts. Interestingly we found 
that addi tion o f an optimal concen tration of the ma st cell stabilizer 
ncdocro mil sodiulTI to o ur co-cul tures partly abrogatcd the lTIa st 
cell-in duced cnhan cement of collagen synthesis. This effect is 
probabl y achieved through the redu ction o f mediator re lease from 
m ast cells rathcr than by a direc t effe ct on fibrobla sts. In fa ct , 
fibro blast basa l production of collagen was not affccted by th e drug 
alo ne. 
In view of the effec ts of m as t ce ll ac tivation 0 11 fibrobla st 
biochemical properti es, it is no w impo rtan t to defin e which are the 
m ast cell- derived mediato rs respo nsibl e fo r bo th the increase in 
fi bro bl as t pro lifera tion and collagen synthesis that we observed in 
o ur systcm . Mast ce ll s re lease a wide spectrum of bio logically active 
compo unds that can exhibit bo th fibrogenic and fibro lytic activi-
ties. For example , histamine w as found to stimu late in a dose-
dependent m anner the proliferatio n o f human and g uinea':pig 
fib roblasts [27,28] and to enh ance colJagen syn thes.is by g uin ea-pig 
skin fi broblas ts [29]. O n th e other hand , the m ast ceIJ-specific 
proteases , tryptase and chymase, can degrade connective tissue 
elemen ts [30] by modulatin g co lJ agenase activi ty [31]. Mast cclJ 
proteases were fo und to incl·ease fib roblast growth as w ell [3 2]. In 
addition, it is impo rtaJlt to poin t o ut that it has been recently shown 
that mas t cell stimul ation results in mRNA synthesis and/or 
production of several cytokin es [33], some of which, such as 
in te rleukin- l , -4, and -6, tumor necrosis factor-a , and transformin g 
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gro wth factor-J3, may have an important role together ·with the 
classic mast cell mediators in mast cell /fibroblast interac tions [34]. 
In summary, utili zing a long- term mast cell /3T3 fibrob last 
co-culture system w e found that repeated rat peritoneal mast cell 
activation by compound 48/80 enhances signifi cantly 3T 3 fibro-
bl ast proli feration and co llagen production. Therefore this is the 
first repo rt that mast cells kept alive and fun ctionalJ y reactive in a 
de fincd ;/1 IIitro microenvironment can directly cause biochemicaJ 
changes in fibrobla sts that are related to fibrosis development. 
Tltis work ",as Suppo,.ted by a research gmllt fro", F isOfl S, U K. 
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